A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD-Reference-Cited by-同舟云学术

A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD

Published:2017-11-15 Issue:17 Volume:18 Page:1833-1843
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Lal Chitra¹,Strange Charlie¹

Affiliation:

1. Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA

Funder

Janssen Asia Pacific

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1403583

Reference73 articles.

1. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD). 2017. Available from: http://goldcopd.org.

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Bronchodilating Drugs for Chronic Obstructive Pulmonary Disease: Current Status and Future Trends

4. The risk and outcomes of pneumonia in patients on inhaled corticosteroids

5. Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled Corticosteroid Withdrawal and Change in Lung Function in Primary Care Patients with Chronic Obstructive Pulmonary Disease in England;Annals of the American Thoracic Society;2022-11

2. A reappraisal of inspiratory capacity in chronic obstructive pulmonary disease: clinical correlates and role of long-acting muscarinic antagonists and long-acting β2 agonists;Expert Review of Respiratory Medicine;2022-06-03

3. Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review;Respiratory Research;2019-12

4. Single Inhaler LABA/LAMA for COPD;Frontiers in Pharmacology;2019-04-25

5. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD);Cochrane Database of Systematic Reviews;2018-12-11